Hide Board Information

Show Board Information

Cynapsus Therapeutics Inc. CYNA

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/25/2015 7:37:30 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Cynapsus Therapeutics Inc. (OTCMRKTS: CYNA) Stock Message Board

1. CYNA Company Profile

    

2. CYNA Time & Sales

    

3. CYNA Recent News

    

4. CYNA Filings

    

5. CYNA Financials

    

6. CYNA Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	$CYNAF on Jason Napodano's watch list for	dawnpatrol	01/25/2015 7:37:30 PM
8	Latest Cynapsus Therapeutic (CYNAF) Headlines	Stock_Tracker	03/09/2014 1:34:11 PM
7	CYNAF 1.18 Stock Charts $CYNAF 1 Month Chart	chartguy89	03/06/2014 6:27:43 PM
6	$CYNAF correcting a new high	PoemStone	02/28/2014 10:19:11 PM
5	CYNAF Stock Charts Last: +0.0131 Tuesday,	chartguy89	02/25/2014 5:50:49 AM
4	$CYNAF new volume breakout $0.89 Shares	PoemStone	01/10/2014 10:17:48 PM
3	latest SA on this one	biomanbaba	06/29/2013 12:38:48 PM
2	Cynapsus is a specialty pharmaceutical company	biomanbaba	06/29/2013 12:22:22 PM
1	Mercy a naked board.......Seel told me to study	biomanbaba	06/29/2013 12:16:43 PM

Recent Articles

• Liven AS Expands Development Footprint with New Property
• Disc Medicine Unveils $250 Million Public Offering Plan
• Disc Medicine Launches Major Stock Offering to Drive Growth
• Exploring Innovations at the Upcoming Global Conference
• Investors Urged to Explore Class Action for Designer Brands
• Buckingham Names John J. Rambacher as Senior Counsel
• Apple's iPhone 17 Sales Surge: Insights on Future Growth
• Tronox Holdings Offers Investors a Path to Justice Through Action
• Retirement and Transition of Leadership in Iron Workers Union
• CEO Marin Katusa Acquires Shares in Carbon Streaming Corporation
• Giboo Unveils Revolutionary No-Cost Fundraising AI Platform
• Groundbreaking AI Insights Propel Silmitasertib in Cancer Treatment
• BGIN Blockchain Limited Prepares For Initial Public Offering
• Understanding Your Rights: Encompass Health Securities Class Action
• Celebrating a Decade of Excellence at KL International School
• BGIN Blockchain Limited Sets Attractive IPO Pricing for Investors
• Elizabeth Warren's Call for Big Tech Breakup Following Outage
• Navigating Dogecoin's Resistance: Insights for Investors
• Airspace Achieves Milestone With Effective Drone Security at Fleet Week
• Empowering Financial Futures at the Seedly Festival
• Cathie Wood's Strategic Portfolio Shift: Insights Into AI Investments
• Cerro de Pasco Resources Announces New Financing Initiative
• Strategic Consolidated Income Fund LLC's Units Acquisition Insight
• BrightSpring Health Services Undertakes Secondary Stock Offering
• Updates on Soleno Therapeutics, Inc. Legal Matters
• Join the Class Action Against Dow Inc. for Investor Rights
• SK Biopharmaceuticals and Eurofarma Unite for AI Epilepsy Management
• Cerro de Pasco Resources Seeks Up to $15 Million Investment
• Casio Launches an Innovative Ring-Sized G-SHOCK Watch
• Introducing the Compact DWN-5600 G-SHOCK: Revolution in Style
• Jasper Therapeutics Shareholders: Your Rights in SEC Lawsuit
• Future Growth of the Silicone Market to Reach $33 Billion
• Exploring the Growth of the Silicone Market Towards 2030
• XORTX Secures Extension to Meet Nasdaq Compliance Goals
• Brunello Cucinelli Faces Allegations of Misleading Information
• Planning for the Future: Bay Area Draft Plan Released
• Key Financing Support for Australia's Critical Mineral Project
• Fortinet Class Action: Key Dates and Investor Guidance
• Revolutionizing Tourism: AMBITIONS ENTERPRISE's IPO Journey
• UPS Innovates Delivery with Air-Conditioned Vehicles Initiative
• Transforming $1000 in Reliance to Significant Returns Over 10 Years
• BioVaxys Converts Debentures and Issues Stock Options
• BioVaxys Moves Forward with Debenture Conversions and Options Grant
• Banorte Recognized for Excellence in Infrastructure Financing
• Purpose Investments Plans Exciting Fund Distributions for Investors
• Rezolve AI Faces Investor Scrutiny Amid Deceptive Claims
• Discover the Value of a $100 Investment in Wintrust Financial
• Grupo Rotoplas Achieves ESG Milestone with ELIS Award 2025
• Baxter International Faces Class Action Amid Allegations of Harm
• Leviathan Gold Transforms with Cura Acquisition Plans and Name Change